BG98628A - The use of peptidoglycan monomer (pgm) and its n-acyl derivatives and metal complexes for the production of medicines for the correction of immunosuppressive and hepatosuppressive conditions of the organism - Google Patents

The use of peptidoglycan monomer (pgm) and its n-acyl derivatives and metal complexes for the production of medicines for the correction of immunosuppressive and hepatosuppressive conditions of the organism

Info

Publication number
BG98628A
BG98628A BG98628A BG9862894A BG98628A BG 98628 A BG98628 A BG 98628A BG 98628 A BG98628 A BG 98628A BG 9862894 A BG9862894 A BG 9862894A BG 98628 A BG98628 A BG 98628A
Authority
BG
Bulgaria
Prior art keywords
hepatosuppressive
immunosuppressive
pgm
conditions
metal complexes
Prior art date
Application number
BG98628A
Other languages
Bulgarian (bg)
English (en)
Inventor
Biserka Radosevi-Stasic
Bozidar Suskovic
Radmila Naumski
Danijel Rukavina
Original Assignee
Pliva Farmaceutska,Kemijska,Prehrambena Ikozmeticka Industrija Dionicko Drustvo
Pliva Handels Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Farmaceutska,Kemijska,Prehrambena Ikozmeticka Industrija Dionicko Drustvo, Pliva Handels Gmbh filed Critical Pliva Farmaceutska,Kemijska,Prehrambena Ikozmeticka Industrija Dionicko Drustvo
Publication of BG98628A publication Critical patent/BG98628A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Addiction (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
BG98628A 1991-08-15 1994-03-01 The use of peptidoglycan monomer (pgm) and its n-acyl derivatives and metal complexes for the production of medicines for the correction of immunosuppressive and hepatosuppressive conditions of the organism BG98628A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
YU141291 1991-08-15
PCT/EP1992/001859 WO1993003746A1 (en) 1991-08-15 1992-08-13 Preparation of medicaments containing the peptidoglycan monomer or its derivatives

Publications (1)

Publication Number Publication Date
BG98628A true BG98628A (en) 1995-06-30

Family

ID=25554075

Family Applications (1)

Application Number Title Priority Date Filing Date
BG98628A BG98628A (en) 1991-08-15 1994-03-01 The use of peptidoglycan monomer (pgm) and its n-acyl derivatives and metal complexes for the production of medicines for the correction of immunosuppressive and hepatosuppressive conditions of the organism

Country Status (10)

Country Link
EP (1) EP0600974A1 (xx)
JP (1) JPH08506796A (xx)
BG (1) BG98628A (xx)
CA (1) CA2115270A1 (xx)
CZ (1) CZ30194A3 (xx)
HR (1) HRP920488A2 (xx)
HU (1) HU9400420D0 (xx)
RU (1) RU94027699A (xx)
SK (1) SK17994A3 (xx)
WO (1) WO1993003746A1 (xx)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU45382B (en) * 1986-11-19 1992-05-28 Pliva Sour Zagreb Process for preparing complex of n-acethyl-glucosis-aminyl-n-acethyl-muramoil-l-alanyl-d-izoglutaminyl-(l)-mezodiaminopimelyl-(d-amid)-(l)-al
US4868155A (en) * 1987-10-05 1989-09-19 Merck & Co., Inc. Dipeptidyl 4-0-,6-0-acyl-2-amino-2-deoxy-D-glucose compositions and methods of use in AIDS-immunocompromised human hosts
YU62689A (en) * 1989-03-27 1991-02-28 Pliva Pharm & Chem Works N-acyl derivatives of peptidoglican monomer, their pharmaceutically acceptable salts, process for preparing thereof and their use as immunity modulators and immunoadjuvant

Also Published As

Publication number Publication date
CA2115270A1 (en) 1993-03-04
EP0600974A1 (en) 1994-06-15
WO1993003746A1 (en) 1993-03-04
JPH08506796A (ja) 1996-07-23
CZ30194A3 (en) 1994-06-15
SK17994A3 (en) 1994-08-10
HU9400420D0 (en) 1994-08-29
RU94027699A (ru) 1996-04-10
HRP920488A2 (en) 1994-08-31

Similar Documents

Publication Publication Date Title
DK602988A (da) Nukleosidderivater med antiviral virkning og laegemiddelpraeparat indeholdende saadanne forbindelser
NO302574B1 (no) Indolkarbazolimider og deres anvendelse
HUP0204023A2 (hu) Pirrolidinacetamidszármazék alkalmazása önmagában vagy kombinációban központi idegrendszeri zavarok kezelésére és ezeket tartalmazó gyógyszerkészítmények
PT87542A (pt) Process for the preparation of a medicament based on indolone derivatives for the treatment of the parkinson disease
IL127352A (en) Pyridyl alkene- and pyridyl alkine-acid amides and pharmaceutical compositions containing them
NO174202C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktivt azainden-derivater
BG86132A (bg) Производни на пиридазинамин
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
MY102016A (en) Thiazolidinedione derivatives, their production and use.
KR950703951A (ko) 광학적으로 순수한 r-케토로락을 포함하는 조성물과 무통과 해열치료에 이를 사용하는 방법(antipyretic and analgesic methods and compositions containing optically pure r-ketorolac)
HUP9900186A2 (hu) Lamellarin alkaloidok gyógyászati alkalmazása és az ezeket tartalmazó gyógyszerkészítmények
YU84503A (sh) Upotreba azitromicina za pripremanje leka za lečenje neinfektivnih inflamatornih oboljenja
NO20053032L (no) Anvendelse av 2,5-dihydroxybenzensulfoniske forbindelser for behandling av lidelser basert pa en forstyrrelse av NO produksjon og/eller av regulering av EDHF funksjon.
BG98628A (en) The use of peptidoglycan monomer (pgm) and its n-acyl derivatives and metal complexes for the production of medicines for the correction of immunosuppressive and hepatosuppressive conditions of the organism
MY139613A (en) Novel piperazinyl-pyrazinone derivatives for the treatment of 5-ht2a receptor-related disorders
IL126795A (en) Pharmaceutical compositions for the treatment of substance abuse disorders comprising pyridyl- and pyrimidyl-piperazines
DE60027691D1 (de) Beta-d-2', 3' -didehydro-2', 3' -didesoxy-5-fluorocytidin für die verwendung in der behandlung von hiv infektionen
UA42693C2 (uk) Лікарський засіб для лікування інфекції лентивірусом, препарат для лікування людини, яка інфікована лентивірусом
KR890001555A (ko) 요산 배설용 조성물
HUP9801545A2 (hu) 2-Metil-4-amino-izotiazolin-3-on-származékok, cisztindiamidok és eljárás ezek előállítására, valamint e vegyületek alkalmazása
EP1731155A3 (en) Beta-d-2', 3' -didehydro-2', 3' -dideoxy-5-fluorocytidine for use in the treatment of hiv infections
RU93037848A (ru) Способ лечения больных лепрой
UA19421C2 (uk) Спосіб лікуваhhя хворих з іhтоксикацією оргаhізму
RU2001102089A (ru) Способ лечения дисциркуляторной энцефалопатии
RU2001123676A (ru) Лекарственное средство для лечения перемежающейся хромоты